Bausch + Lomb Financial Statements
NYSE: BLCOHealth CareOphthalmic GoodsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Bausch + Lomb revenue and earnings
In fiscal 2025, Bausch + Lomb generated $5.10 billion in revenue, up 6.5% from fiscal 2024, its 5th consecutive year of revenue growth. Bausch + Lomb reported a net loss of $360.0 million, compared with a loss of $317.0 million a year earlier. Operating margin was 2.2%.
Diluted earnings per share came in at -$1.02. Over the last 5 fiscal years, BLCO's revenue has grown at a 8.4% compound annual rate.
Summary generated from market data by MetaCap's automated system. Methodology
Bausch + Lomb income statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 |
|---|---|---|---|---|---|---|
| Revenue | 5.10B | 4.79B | 4.15B | 3.77B | 3.77B | 3.41B |
| Revenue growth (YoY) | +6.47% | +15.56% | +10.03% | +0.08% | +10.35% | — |
| Research & Development | 371.00M | 343.00M | 324.00M | 307.00M | 271.00M | 253.00M |
| Selling, General & Admin | 2.23B | 2.08B | 1.74B | 1.48B | 1.39B | 1.25B |
| Operating Income | 113.00M | 162.00M | 130.00M | 207.00M | 329.00M | 260.00M |
| Interest Expense | 421.00M | 399.00M | 283.00M | 146.00M | 0 | 0 |
| Other Income (Expense) | — | — | -74.00M | -13.00M | -17.00M | -38.00M |
| Pretax Income | -317.00M | -234.00M | -166.00M | 73.00M | 318.00M | 290.00M |
| Income Tax | 35.00M | 71.00M | 82.00M | 58.00M | 125.00M | 307.00M |
| Net Income | -360.00M | -317.00M | -260.00M | 6.00M | 182.00M | -18.00M |
| Net Income growth (YoY) | — | — | -4433.33% | -96.70% | — | — |
| EPS (Basic) | -1.02 | -0.90 | -0.74 | 0.02 | 0.52 | -0.05 |
| EPS (Diluted) | -1.02 | -0.90 | -0.74 | 0.02 | 0.52 | -0.05 |
| Shares Outstanding (Basic) | 353.80M | 351.80M | 350.50M | 350.00M | 350.00M | 350.00M |
| Shares Outstanding (Diluted) | 353.80M | 351.80M | 350.50M | 350.20M | 350.00M | 350.00M |
| EBITDA | 534.00M | 598.00M | 512.00M | 586.00M | 744.00M | 702.00M |
| Operating Margin | 2.22% | 3.38% | 3.14% | 5.49% | 8.74% | 7.62% |
| Net Margin | -7.06% | -6.62% | -6.27% | 16.00% | 4.83% | -53.00% |
This table shows 6 annual periods of Bausch + Lomb's income statement, from FY 2025 back to FY 2020, across 16 line items including revenue, research & development, selling, general & admin. Values in USD; B = billions, M = millions. Fiscal periods follow BLCO's reporting calendar. What is a income statement?